D. Holt

P. Syrris, D. Holt, I. Macphee, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Tacrolimus Pharmacogenetics: The CYP3A5*1 Allele Predicts Low Dose-Normalized Tacrolimus Blood Concentrations in Whites and South Asians

D. Holt, I. Macphee, M. Moreton, 2005, Transplantation.

Myocardial damage : early detection by novel biochemical markers

J. Kaski, D. Holt, 1998 .

Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.

L. Shaw, D. Holt, B. Kahan, 1990, Clinical chemistry.

Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine.

L. Shaw, D. Holt, B. Kahan, 1990, Transplantation proceedings.

The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine.

J. Kovarik, D. Holt, E. Mueller, 1994, Transplantation proceedings.

Genotyping cytochrome P450 3A5 using the Light Cycler

D. Holt, I. Macphee, M. Moreton, 2005, Annals of clinical biochemistry.

Optimizing the use of cyclosporine in renal transplantation.

D. Holt, P. Keown, I. Sketris, 1995, Clinical biochemistry.

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

V. Haufroid, L. Weber, V. Armstrong, 2009, Therapeutic drug monitoring.

Markers of myocardial damage.

D. Holt, S. Fredericks, G. Merton, 1998, Clinical chemistry.

International Federation of Clinical Chemistry/International Association of Therapeutic Drug Monitoring and Clinical Toxicology Working Group on Immunosuppressive Drug Monitoring

L. Shaw, V. Armstrong, A. Griesmacher, 2002, Therapeutic drug monitoring.

Current Issues in Therapeutic Drug Monitoring of Mycophenolic Acid: Report of a Roundtable Discussion

L. Shaw, B. Meiser, D. Holt, 2001, Therapeutic drug monitoring.

The relative proportions of sirolimus metabolites in blood using HPLC with mass-spectrometric detection.

D. Holt, D. McKeown, A. Johnston, 2004, Transplantation proceedings.

Therapeutic monitoring of sirolimus: its contribution to optimal prescription.

D. Holt, A. Johnston, T. D. Lee, 2003, Transplantation proceedings.

Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection.

D. Holt, T. Lee, A. Johnston, 2000, Clinical chemistry.

Method Development for the Detection of Basic/Weak Basic Drugs in Hair by LCMSMS: Comparison between Methanolic and Alkaline Extraction on Real Samples

D. Holt, J. Jaber, A. Johnston, 2012 .

Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries. Coronary Artery Disease Research Group.

J. Kaski, O. Salomone, D. Holt, 1998, American heart journal.

The Pharmacogenetics of Immunosuppression for Organ Transplantation

D. Holt, I. Macphee, S. Fredericks, 2003 .

Effects of modified ultrafiltration on coagulation as measured by the thromboelastograph.

T. Kohmoto, D. Holt, N. Edwards, 2008, The journal of extra-corporeal technology.

Monitoring Immunosuppressive Drugs: Has It a Future?

D. Holt, A. Johnston, 2004, Therapeutic drug monitoring.

Cardiac troponin T and creatine kinase MB are not increased in exterior oblique muscle of patients with renal failure.

P. Collinson, D. Holt, M. Bewick, 2001, Clinical Chemistry.

Neuropsychological change and S-100 protein release in 130 unselected patients undergoing cardiac surgery.

T. Treasure, D. Holt, S. Kilminster, 1999, Stroke.

The need for standardization of tacrolimus assays.

D. Holt, D. Levine, G. O’Connor, 2011, Clinical chemistry.

Influence of intraoperative fluid volume on cardiopulmonary bypass hematocrit and blood transfusions in coronary artery bypass surgery.

S. Durham, D. Holt, V. Shostrom, 2008, The journal of extra-corporeal technology.

Current opinions on therapeutic drug monitoring of immunosuppressive drugs.

L. Shaw, D. Holt, P. Keown, 1999, Clinical therapeutics.

Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population.

Qingbo Xu, M. Mayr, S. Kiechl, 2009, Atherosclerosis.

New approaches to cyclosporine monitoring raise further concerns about analytical techniques.

L. Shaw, D. Holt, M. Oellerich, 2000, Clinical chemistry.

Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.

C. Davis, D. Holt, I. Macphee, 2000, Kidney international.

Digoxin measurements in general practice.

D. Holt, G. Volans, J. Williamson, 1977, British journal of clinical pharmacology.

Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus

S. Epstein, D. Holt, K. Rutault, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression.

J. Kaski, X. Garcia-Moll, D. Holt, 2001, European heart journal.

Elevated serum levels of soluble interleukin‐2 receptor, neopterin and β‐2‐microglobulin in idiopathic dilated cardiomyopathy: relation to disease severity and autoimmune pathogenesis

A. Dalgleish, J. Goldman, D. Holt, 2001, European journal of heart failure.

Pre-Clinical Application of Markers of Myocardial Damage

D. Holt, 1998 .

Circulating cardiac troponin-T in patients before and after renal transplantation.

P. Collinson, D. Holt, D. Gaze, 2001, Clinica chimica acta; international journal of clinical chemistry.

Pregnancy-associated plasma protein-A and cardiovascular risk.

J. Kaski, D. Holt, 2006, European heart journal.

A controlled trial of substrate-enhanced, warm reperfusion ("hot shot") versus simple reperfusion.

T. Treasure, D. Holt, A. Murday, 2000, The Annals of thoracic surgery.

Plasma Concentrations of Inflammatory Cytokines Rise Rapidly during ECMO-related SIRS due to the Release of Pre-formed Stores in the Intestine

R. Schelonka, D. Holt, C. Killingsworth, 2009, Laboratory Investigation.

HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimus.

D. C. French, D. Holt, D. Hicks, 2001, Clinical chemistry.

Pharmacokinetics of Sirolimus and Tacrolimus in Pediatric Transplant Patients

L. Shaw, J. Reyes, D. Holt, 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Pharmacogenomics of immunosuppressive drug metabolism

D. Holt, S. Fredericks, 2003, Current opinion in nephrology and hypertension.

Amiodarone pharmacokinetics.

G. Tucker, D. Holt, G. Storey, 1983, American heart journal.

Methodological and Clinical Aspects of Cyclosporin Monitoring: Report of the Association of Clinical Biochemists Task Force

J. Tredger, D. Holt, N. Roberts, 1994, Annals of clinical biochemistry.

Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms.

P. Elliott, J. Kaski, O. Salomone, 1995, British heart journal.

Myocardial magnesium depletion associated with prolonged hypomagnesemia: a longitudinal study in heart transplant recipients.

W. Mckenna, A. Camm, D. Holt, 1992, Journal of the American College of Cardiology.

Effect of denervation on the content of cardiac troponin-T and cardiac troponin-I in rat skeletal muscle.

P. Collinson, D. Holt, H. Degens, 2007, Clinical biochemistry.

Cardiac troponin T and creatine kinase MB content in skeletal muscle of the uremic rat.

P. Collinson, D. Holt, D. Gaze, 2002, Clinical chemistry.

The effect of vehicle on the oral absorption of cyclosporin.

D. Holt, J. Henry, A. Johnston, 1986, British journal of clinical pharmacology.

Improving hemolysis levels associated with cardiotomy suction

D. Holt, Jared Arensdorf, Halle Petitt, 2018, Perfusion.

Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?

D. Holt, I. Macphee, S. Fredericks, 2005, Expert opinion on pharmacotherapy.

Effects of conventional ultrafiltration on renal performance during adult cardiopulmonary bypass procedures.

D. Holt, Bryan E. Thacker, Rick A. Kuntz, 2006, The journal of extra-corporeal technology.

Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals.

D. Holt, N. Carter, P. Heining, 2001, Clinica chimica acta; international journal of clinical chemistry.

Evaluation of fetal arrhythmias by echocardiography.

S. Campbell, D. Holt, M. Tynan, 1983, British heart journal.

Creatine kinase MB isoforms: a potential predictor of acute cardiac allograft rejection.

D. Holt, C. Corbishley, J. Anderson, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Creatine kinase isoforms as circulating markers of deterioration in idiopathic dilated cardiomyopathy

J. Goldman, P. Keeling, D. Holt, 1996, Clinical Cardiology.

Improving Decreased Heater-Cooler Efficiency as a Result of Heater-Cooler Infection Control Strategy.

D. Holt, Adam K Blakey, 2019, The journal of extra-corporeal technology.

Acute changes in atrial natriuretic peptide, insulin-like growth factor-1, and lactate levels during left anterior descending coronary artery angioplasty.

W. Mckenna, A. Camm, J. Gill, 1995, American heart journal.

Colloid Oncotic Pressure, Monitoring its Effects in Cardiac Surgery.

D. Holt, J. Chores, 2017, The journal of extra-corporeal technology.

Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM])

J. Ramsey, P. Dargan, D. Holt, 2008, Journal of Medical Toxicology.

Detection of the pharmaceutical agent glaucine as a recreational drug

J. Ramsey, P. Dargan, D. Holt, 2008, European Journal of Clinical Pharmacology.

Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris.

J. Kaski, O. Salomone, D. Holt, 1998, American heart journal.

Using midazolam to monitor changes in hepatic drug metabolism in critically ill patients

D. Holt, B. Philips, I. Macphee, 2009, Intensive Care Medicine.

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement

P. Syrris, D. Holt, I. Macphee, 2002, Transplantation.

Heparin dose and postoperative bleeding in patients undergoing cardiopulmonary bypass.

D. Holt, M. Rosin, 2013, The journal of extra-corporeal technology.

Myocardial Injury Induced by Radiofrequency and Low Energy Ablation: A Quantitative Study of CK Isoforms, CK‐MB, and Troponin‐T Concentrations

A. Camm, A. Camm, J. Poloniecki, 1998, Pacing and clinical electrophysiology : PACE.

Creatine Kinase Isoforms

D. Holt, 1998 .

A MICROPARTICLE ENZYME IMMUNOASSAY TO MEASURE SIROLIMUS

D. Holt, K. Laamanen, M. Moreton, 2004, Transplantation proceedings.

Creatine kinase MB isoforms: sensitive markers of ischemic myocardial damage.

T. Treasure, D. Holt, A. Murday, 1994, Clinical chemistry.

Quality assessment of cyclosporine measurements: comparison of current methods.

D. Holt, A. Johnston, J. Marsden, 1990, Transplantation proceedings.

Effect of age and plasma concentrations of albumin and alpha 1-acid glycoprotein on protein binding of disopyramide.

D. Holt, G. Healey, A. Hayler, 1983, British journal of clinical pharmacology.

Generic substitution for cyclosporine: what should we be looking for in new formulations?

D. Holt, A. Johnston, 1998, Transplantation proceedings.

Use of autologous platelet gel in bariatric surgery.

D. Holt, C. Brady, S. Vang, 2006, The journal of extra-corporeal technology.

Lidocaine increases lung uptake of propranolol

D. Geddes, J. Pang, D. Holt, 2007, Lung.

Breath pentane and heart rejection.

J. Ramsey, D. Holt, A. Johnston, 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Mycophenolate Mofetil: A Report of the Consensus Panel

L. Shaw, D. Holt, R. Morris, 1995, Therapeutic drug monitoring.

Autologous platelet gel and platelet-poor plasma reduce pain with total shoulder arthroplasty.

D. Holt, V. Shostrom, Jaime M Costigan, 2007, The journal of extra-corporeal technology.

Immunosuppressant drugs--the role of therapeutic drug monitoring.

D. Holt, A. Johnston, A. Johnston, 2001, British journal of clinical pharmacology.

Therapeutic drug monitoring of immunosuppressant drugs.

D. Holt, A. Johnston, A. Johnston, 1999, British journal of clinical pharmacology.

Vicarious audiovisual learning in perfusion education.

D. Holt, T. Rath, 2010, The journal of extra-corporeal technology.

Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.

B. Tönshoff, J. Chapman, D. Cattaneo, 2010, Clinical journal of the American Society of Nephrology : CJASN.

Amiodarone dose titration: a method to minimise side effects during long term therapy.

W. Mckenna, L. Harris, D. Holt, 1986, British journal of clinical practice. Supplement.

Creatine kinase MB2 isoform release as a marker of perioperative myocardial damage during cardiac transplantation.

T. Treasure, D. Holt, P. Kallis, 1994, Clinical biochemistry.

CreatineKinaseMB Isoforms: SensitiveMarkersof IschemicMyocardialDamage

T. Treasure, D. Holt, A. Murday, 1994 .

Peripheral neutrophil inclusions in amiodarone treated patients.

A. Morley, D. Holt, P. Sloan, 1986, British journal of clinical pharmacology.

Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.

G. Mazariegos, J. Reyes, J. Fung, 2001, Transplantation.

Blood cyclosporin concentrations and renal allograft dysfunction.

D. Holt, M. Bewick, A. Johnston, 1986, British medical journal.

Measurement of cardiac troponin I in striated muscle using three experimental methods

P. Collinson, D. Holt, N. Carter, 2003, Annals of clinical biochemistry.

Donor cardiac troponin-T predicts subsequent inotrope requirements following cardiac transplantation.

D. Holt, J. Anderson, A. Murday, 1994, Transplantation.

Simultaneous Determination of Plasma Prednisolone, Prednisone, and Cortisol Levels by High-Performance Liquid Chromatography

D. Holt, F. Akhlaghi, A. Trull, 2001, Therapeutic drug monitoring.

Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.

D. Holt, I. Macphee, N. Ekbal, 2008, Pharmacogenomics.

Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation

D. Holt, I. Macphee, F. Ng, 2007, Expert opinion on pharmacotherapy.

Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris.

J. Kaski, M. Christiansen, D. Holt, 2008, Clinica chimica acta; international journal of clinical chemistry.

Intraoperative assessment and quantification of coronary artery graft patency performed on or off cardiopulmonary bypass.

D. Holt, K. Strutz, E. Rauch, 2007, The journal of extra-corporeal technology.

Therapeutic drug monitoring of cyclosporine.

D. Holt, A. Johnston, A. Jorga, 2004, Transplantation proceedings.

Chapter 11 – Monitoring immunosuppressive drugs

D. Holt, A. Johnston, A. Johnston, 2004 .

Paradoxical response to tacrolimus assessed by interleukin-2 gene expression.

D. Holt, I. Macphee, A. Johnston, 2006, Transplantation proceedings.

A limited sampling strategy for the measurement of cyclosporine AUC.

D. Holt, I. Sketris, C. Galustian, 1990, Transplantation Proceedings.

Therapeutic drug monitoring of immunosuppressive drugs in kidney transplantation

D. Holt, 2002, Current opinion in nephrology and hypertension.

Normoxia vs. hyperoxia: impact of oxygen tension strategies on outcomes for patients receiving cardiopulmonary bypass for routine cardiac surgical repair.

D. Holt, D. Brown, R. J. Burnett, 2006, The journal of extra-corporeal technology.

Optimizing the use of cyclosporin in renal transplantation

D. Holt, P. Keown, I. Sketris, 1995 .

Quantification of mycophenolic acid in human plasma by liquid chromatography with time-of-flight mass-spectrometry for therapeutic drug monitoring.

L. Couchman, D. Holt, G. De Nucci, 2020, Biomedical chromatography : BMC.

Monitoring mycophenolic acid

D. Holt, 2002, Annals of clinical biochemistry.

Discussion: can upper extremity (deltoid) near infrared spectroscopy be used to assess cerebral tissue bed saturation on femorally cannulated veno-arterial extracorporeal membrane oxygenation patients?

D. Holt, H. Takayama, K. Takeda, 2020, Perfusion.

Rapid Quantitation of Flecainide in Human Plasma for Therapeutic Drug Monitoring Using Liquid Chromatography and Time-of-Flight Mass Spectrometry

L. Couchman, D. Holt, T. El-Nahhas, 2019, Therapeutic drug monitoring.

Osteoarthritis in temporomandibular joint of Col2a1 mutant mice.

P. Reynolds, L. Bridgewater, B. A. Nichols, 2013, Archives of oral biology.

Proficiency-testing issues relating to sirolimus.

D. Holt, A. Johnston, K. Jones, 2000, Clinical therapeutics.

Consensus Guidelines for Therapeutic Drug Monitoring of Rapamycin: Report of the Consensus Panel

D. Holt, S. Soldin, R. Boeckx, 1995, Therapeutic drug monitoring.

Response to ciclosporin treatment in Ethiopian and Nepali patients with severe leprosy Type 1 reactions.

D. Lockwood, D. Holt, A. Anderson, 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Are there benefits to a fresh whole blood vs. packed red blood cell cardiopulmonary bypass prime on outcomes in neonatal and pediatric cardiac surgery?

D. Holt, D. Geiss, Klayton W. Buckley, 2007, The journal of extra-corporeal technology.

Oxygenators for Extracorporeal Circulation

D. Holt, P. Beckley, R. Tallman, 1995 .

Insensible water loss from the Jostra Quadrox D oxygenator: an in vitro study

D. S. Lawson, D. Holt, DS Lawson, 2007, Perfusion.

Can vacuum assisted venous drainage be achieved using a roller pump in an emergency? A pilot study using neonatal circuitry.

D. Holt, S. Hill, B. R. M. S. L. Hill, 2007, The journal of extra-corporeal technology.

Removal of Gross Air Embolization from Cardiopulmonary Bypass Circuits with Integrated Arterial Line Filters: A Comparison of Circuit Designs.

D. Holt, J. Reagor, 2016, The journal of extra-corporeal technology.

Implementation of a Prescriptive Extracorporeal Circuit and Its Effect on Hemodilution and Blood Product Usage during Cardiac Surgery.

Charles C. Miller, C. Miller, H. Sandhu, 2020, The journal of extra-corporeal technology.

Modification of sodium, glucose, potassium, and osmolarity in packed red blood cells and fresh frozen plasma using a desktop hemoconcentrator setup.

D. Holt, Carrie Whittaker Striker, Stacia Woldorf, 2012, The journal of extra-corporeal technology.

In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass.

D. Holt, Lynette M. Smith, Angela Ask, 2006, The journal of extra-corporeal technology.

Delayed onset of seizures and toxicity associated with recreational use of Bromo-dragonFLY

J. Ramsey, P. Dargan, D. Holt, 2009, Journal of Medical Toxicology.

Micro method of analysis for magnesium in myocardial biopsies.

D. Holt, T. Millane, T. Fashola, 1991, Clinical chemistry.

Effective synthesis of 1beta-acyl glucuronides by selective acylation.

D. Holt, A. Stachulski, J. Harding, 2005, Organic letters.

Convenient syntheses of the in vivo carbohydrate metabolites of mycophenolic acid: reactivity of the acyl glucuronide

H. K. Wilson, V. Armstrong, D. Holt, 2009 .

AMIODARONE IN TESTIS AND SEMEN

D. Holt, P. Adams, P. Holt, 1985, The Lancet.

Purchasing 'legal highs' on the Internet--is there consistency in what you get?

J. Ramsey, P. Dargan, D. Holt, 2010, QJM : monthly journal of the Association of Physicians.

‘Ivory wave’ toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning

J. Ramsey, J. Dear, D. Murray, 2012, Clinical toxicology.

Energy-1 (‘NRG-1’): don't believe what the newspapers say about it being legal

J. Ramsey, P. Dargan, D. Holt, 2011, Emergency Medicine Journal.

Energy-1 (‘NRG-1’): don't believe what the newspapers say about it being legal

J. Ramsey, P. Dargan, D. Holt, 2011, BMJ Case Reports.

Case series of individuals with analytically confirmed acute mephedrone toxicity

David W. Holt, John Ramsey, J. Ramsey, 2010, Clinical toxicology.

Buying 'legal' recreational drugs does not mean that you are not breaking the law.

J. Ramsey, P. Dargan, D. Holt, 2010, QJM : monthly journal of the Association of Physicians.

Recreational Use of Mephedrone (4-Methylmethcathinone, 4-MMC) with Associated Sympathomimetic Toxicity

David W. Holt, John Ramsey, J. Ramsey, 2010, Journal of Medical Toxicology.

Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP)

J. Ramsey, P. Dargan, D. Holt, 2008, Journal of Medical Toxicology.

First case report of recreational use of 2,5-dimethoxy-4-chloroamphetamine confirmed by toxicological screening.

J. Ramsey, P. Dargan, D. Holt, 2008, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Collapse, reported seizure—and an unexpected pill

J. Ramsey, P. Dargan, D. Holt, 2007, The Lancet.

Analysis for Identification in Amnesty Bin Samples from Dance Venues

J. Ramsey, D. Holt, A. Johnston, 2005, Therapeutic drug monitoring.

Therapeutic Drug Monitoring of Everolimus: A Consensus Report

P. Marquet, C. Seger, K. Budde, 2016, Therapeutic drug monitoring.

Autologous platelet gel: an in vitro analysis of platelet-rich plasma using multiple cycles.

D. Holt, John Anderson, C. Brady, 2006, The journal of extra-corporeal technology.

Quality assessment of platelet rich plasma during anti-platelet therapy

D. Holt, R. Binford, D. Webb, 2007, Perfusion.

High performance liquid chromatographic measurement of bisoprolol in plasma.

D. Holt, R. Bhamra, R. Eastwood, 1990, Biomedical chromatography : BMC.

Methylene blue-induced methemoglobinemia during cardiopulmonary bypass? A case report and literature review.

D. Holt, C. McRobb, 2008, The journal of extra-corporeal technology.

Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus Panel

M. Oellerich, T. Annesley, V. Armstrong, 1995, Therapeutic drug monitoring.

How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients.

D. Holt, T. van Gelder, J. Klupp, 2002, Transplant immunology.

Osteoarthritis-like changes in the heterozygous sedc mouse associated with the HtrA1-Ddr2-Mmp-13 degradative pathway: a new model of osteoarthritis.

L. Bridgewater, D. Holt, D. Kooyman, 2012, Osteoarthritis and cartilage.

Efavirenz detectable in plasma 8 weeks after stopping therapy and subsequent development of non-nucleoside reverse transcriptase inhibitor-associated resistance.

S. Khoo, D. Holt, S. T. Sadiq, 2005, AIDS.

High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant women.

D. Holt, M. Sharland, D. McKeown, 2010, AIDS.

Measurement of plasma disopyramide as a guide to paediatric use.

D. Holt, M. Tynan, E. Baker, 1986, International journal of cardiology.

Paediatric use of mexiletine and disopyramide.

D. Holt, M. Tynan, P. Curry, 1979, British medical journal.

Experimental disopyramide poisoning: treatment by cardiovascular support and with charcoal hemoperfusion.

D. Holt, A. Hayler, R. Medd, 1979, The Journal of pharmacology and experimental therapeutics.

Biomarkers of disease: an evidence-based approach.

J. Tredger, C. Price, D. Holt, 2002 .

Substandard drugs: a potential crisis for public health

Atholl Johnston, D. Holt, David W Holt, 2013, British journal of clinical pharmacology.

Simultaneous determination of tramadol, O-desmethyltramadol and N-desmethyltramadol in human urine by gas chromatography-mass spectrometry.

D. Holt, K. Mohamed, A. El-Sayed, 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Measurement of cyclosporine: methodological problems.

D. Holt, A. Johnston, J. Marsden, 1986, Transplantation proceedings.

Determination of total mycophenolic acid and its glucuronide metabolite using liquid chromatography with ultraviolet detection and unbound mycophenolic acid using tandem mass spectrometry.

D. Holt, A. Mendonza, F. Akhlaghi, 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Quality assessment issues of new immunosuppressive drugs and experimental experience.

D. Holt, A. Johnston, T. Lee, 1996, Therapeutic drug monitoring.

Autologous platelet gel in coronary artery bypass grafting: effects on surgical wound healing.

D. Holt, John Anderson, C. Brady, 2007, The journal of extra-corporeal technology.

Simple gas-liquid chromatographic method for the measurement of mexiletine and lignocaine in blood-plasma or serum.

D. Holt, R. Flanagan, M. Loizou, 1979, Journal of chromatography.

Simple method for the measurement of tocainide and lignocaine in blood plasma or serum using gas--liquid chromatography with flame ionisation detection.

D. Holt, R. Flanagan, S. Gettings, 1981, Journal of chromatography.

Validation of high-performance liquid chromatographic-mass spectrometric method for the analysis of lidocaine in human plasma.

D. Holt, A. Tucker, Z. Chik, 2006, Journal of chromatographic science.

Therapeutic monitoring of mycophenolic acid: A consensus panel report

L. Shaw, V. Armstrong, P. Halloran, 1998 .

High performance liquid chromatographic measurement of lignocaine in tissue samples following transabdominal placental biopsy.

D. Holt, R. Flanagan, S. Monkman, 1989, Biomedical chromatography : BMC.

Is fibreoptic bronchoscopy in patients with lung cancer and hepatic metastases potentially dangerous?

D. Holt, D. P. Dhillon, J. Collins, 1985, British journal of diseases of the chest.

Gas-liquid chromatographic measurement of lignocaine in small samples of canine myocardium after enzymatic digestion.

D. Holt, R. Wyse, M. Loizou, 1979, Journal of clinical pathology.

Chronic Severe Hyponatremia and Cardiopulmonary Bypass: Avoiding Osmotic Demyelination Syndrome.

D. Holt, J. Rowles, J. Fisher, 2015, The journal of extra-corporeal technology.

Penetration of digoxin into cerebrospinal fluid.

G. Schott, D. Holt, A. Hayler, 1976, Postgraduate medical journal.

Stability of plasma amiodarone levels during chronic oral therapy

D. Holt, W. McKenna, A. Johnston, 1990, Cardiovascular Drugs and Therapy.

A trial of prophylactic mexiletine in home coronary care.

D. Holt, N. Snell, J. Bell, 1982, British heart journal.

A Schedule for Combined Intravenous and Oral Dosing with Mexiletine

D. Holt, Gerhardt Hampel, Glyn N Volans, 1979, The Journal of international medical research.

Cardiopulmonary bypass in the cat.

D. Holt, E. Schertel, J. D. Brourman, 2002, Veterinary surgery : VS.

Variability in the 3,4-methylenedioxymethamphetamine content of ‘ecstasy’ tablets in the UK

J. Ramsey, P. Dargan, D. Holt, 2010, Emergency Medicine Journal.

A new method to monitor drugs at dance venues

J. Ramsey, D. Holt, A. Johnston, 2001, BMJ : British Medical Journal.

Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).

J. Ramsey, P. Dargan, D. Holt, 2007, QJM : monthly journal of the Association of Physicians.

What evidence is there that the UK should tackle the potential emerging threat of methamphetamine toxicity rather than established recreational drugs such as MDMA ('ecstasy')?

J. Ramsey, P. Dargan, D. Holt, 2008, QJM : monthly journal of the Association of Physicians.

Medical and legal confusion surrounding gamma-hydroxybutyrate ( GHB ) and its precursors gamma-butyrolactone ( GBL ) and 1 , 4-butanediol ( 1 , 4 BD )

J. Ramsey, P. Dargan, D. Holt, 2008 .

Use of amiodarone in childhood.

G. Sutherland, D. Holt, P. Curry, 1986, British journal of clinical practice. Supplement.

Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?

J. Kaski, I. Tentes, D. Tziakas, 2007, Journal of the American College of Cardiology.

Randomized trial of the Terumo Capiox FX05 oxygenator with integral arterial filter versus Terumo Capiox Baby RX05 and Terumo Capiox AF02 arterial filter in infants undergoing cardiopulmonary bypass.

D. Zurakowski, R. Jonas, D. Holt, 2011, The journal of extra-corporeal technology.

Hyperthermia in extracorporeal technology

D. Holt, 1989 .

Hemoglobin test result variability and cost analysis of eight different analyzers during open heart surgery.

D. Holt, K. Patel, David W Holt, 2007, The journal of extra-corporeal technology.

Bioequivalence criteria for cyclosporine.

D. Holt, A. Johnston, 1999, Transplantation proceedings.

Class III Antiarrhythmics in Overdose

D. Holt, W. McKenna, E. Leatham, 1993, Drug safety.

Use of recombinant factor VIIa (NovoSeven) in pediatric cardiac surgery.

D. Holt, H. Burkhart, S. Niles, 2008, The journal of extra-corporeal technology.

Successful management of serious disopyramide poisoning.

D. Holt, B. O’Keeffe, G. Cook, 1980, Postgraduate medical journal.

Cyclosporin A: Analytical Methodology and Factors Affecting Therapeutic Drug Monitoring

D. Holt, A. Johnston, 1995, Therapeutic Drug Monitoring.

TGF-?? QUANTITATION CAN BE TRICKY

D. Holt, S. Fredericks, 1999 .

High-performance liquid chromatographic measurement of prazosin and terazosin in biological fluids.

D. Holt, R. Flanagan, R. Bhamra, 1986, Journal of chromatography.

The continuing need for quality assessment of cyclosporine measurement.

D. Holt, A. Johnston, J. Marsden, 1989, Clinical chemistry.

Cyclosporin Microemulsion

D. Holt, A. Johnston, A. Johnston, 1997, BioDrugs.

Accuracy of Cyclosporin Measurements Made in Capillary Blood Samples Obtained by Skin Puncture

D. Holt, A. Johnston, G. Merton, 2000, Therapeutic drug monitoring.

Tacrolimus quality assessment.

D. Holt, A. Johnston, 1997, Therapeutic drug monitoring.

Urinary Protein Excretion and the Diagnosis of Graft Rejection or Renal Dysfunction in Renal Transplant Patients

D. Holt, P. Foxall, G. Mellotte, 1993, Human & experimental toxicology.

Multidrug resistance gene-1 (MDR-1) haplotypes have a minor influence on tacrolimus dose requirements.

D. Holt, I. Macphee, M. Moreton, 2006, Transplantation.

CYP3A5 Genotype Had no Impact on Intrapatient Variability of Tacrolimus Clearance in Renal Transplant Recipients

D. Holt, I. Macphee, N. Spierings, 2013, Therapeutic drug monitoring.

Tacrolimus dose in black renal transplant recipients.

D. Holt, N. Vadivel, I. Macphee, 2007, Transplantation.

Management of cardiac drug overdose.

D. Holt, G. Volans, C. Ali, 1984, Resuscitation.

Cardiac consequences and treatment of disopyramide intoxication: experimental evaluation in dogs.

D. Holt, B. O’Keeffe, A. Hayler, 1979, Cardiovascular research.

Treatment of Disopyramide Overdosage

D. Holt, A. Hayler, R. Medd, 1979, The Medical journal of Australia.

A pharmacogenetic strategy for immunosuppression based on the CYP3A5 genotype.

D. Holt, I. Macphee, 2008, Transplantation.

34 TACROLIMUS EXTERNAL QUALITY ASSESSMENT, THE EUROPEAN EXPERIENCE

D. Holt, A. Johnston, Terry D. Lee, 1997 .

Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups.

D. Holt, I. Macphee, F. Ng, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Monitoring Cyclosporin in Blood: Between-Assay Differences at Trough and 2 Hours Post-dose (C2)

D. Holt, E. Schütz, M. Oellerich, 2003, Therapeutic drug monitoring.

Postmortem assay of digoxin by radioimmunoassay.

D. Holt, J. Benstead, 1975, Journal of clinical pathology.

Which cyclosporin formulation?

D. Holt, A. Johnston, 1996, The Lancet.

Evaluating the efficacy of intra-aortic balloon pump timing using the auto-timing mode of operation with the Datascope CS100.

D. Holt, Melissa K Osentowski, 2007, The journal of extra-corporeal technology.

Analysis of recreational drug samples obtained from patients presenting to a busy inner-city emergency department: a pilot study adding to knowledge on local recreational drug use

J. Button, J. Ramsey, P. Dargan, 2010, Emergency Medicine Journal.

Internet-based virtual classroom and educational management software enhance students' didactic and clinical experiences in perfusion education programs.

B. Searles, D. Holt, E. Darling, 2004, The journal of extra-corporeal technology.

CONTROL OF THE VENTRICULAR RESPONSE WITH ORAL AMIODARONE IN PATIENTS WITH RAPIDLY CONDUCTED ATRIAL-FIBRILLATION COMPLICATING THE WOLFF-PARKINSON-WHITE SYNDROME

W. Mckenna, L. Harris, D. Holt, 1981 .

Intravenous and oral amiodarone for arrhythmias in children.

G. Sutherland, D. Holt, M. Tynan, 1986, British heart journal.

Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics.

D. Holt, E. Shinebourne, E. Rowland, 1989, British heart journal.

Experience with flecainide for the treatment of cardiac arrhythmias in children.

E. Rosenthal, D. Holt, M. Tynan, 1988, European heart journal.

Cyclosporin assay techniques. Accuracy and reproducibility variables impacting on measurements.

D. Holt, A. Johnston, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Practical Applications of Therapeutic Drug Monitoring: The impact of technological developments

David W. Holt, Atholl Johnston, D. Holt, 1989 .

Monitoring cyclosporin: is it still important?

D. Holt, A. Johnston, T. Fashola, 1991, Immunology letters.

Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation.

A. Camm, D. Holt, A. Anastasakis, 1997, European heart journal.

Soluble vascular cell adhesion molecule-1 following cardiac transplantation.

D. Holt, J. Anderson, A. Murday, 1995, Transplantation.

HPLC measurement of diltiazem and desacetyldiltiazem in serum or plasma.

D. Holt, R. Bhamra, A. E. Ward, 1987, Biomedical chromatography : BMC.

Effects of ECMO Simulations and Protocols on Patient Safety.

D. Holt, F. Thomas, Sunyoung Chung, 2019, The journal of extra-corporeal technology.

High-performance liquid chromatographic method for the measurement of mexiletine and flecainide in blood plasma or serum.

D. Holt, R. Flanagan, R. Bhamra, 1984, Journal of chromatography.

High-performance liquid chromatographic measurement of atenolol: methodology and clinical applications.

D. Holt, K. Thorley, R. Bhamra, 1983, Therapeutic drug monitoring.

Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 - A potential risk to users?

J. Ramsey, L. Couchman, D. Holt, 2019, Drug testing and analysis.

Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris.

J. Kaski, M. Overgaard, M. Christiansen, 2005, European heart journal.

Pregnancy-Associated Plasma Protein A and Its Endogenous Inhibitor, the Proform of Eosinophil Major Basic Protein (proMBP), Are Related to Complex Stenosis Morphology in Patients With Stable Angina Pectoris

J. Kaski, M. Overgaard, M. Christiansen, 2004, Circulation.

Long‐term evaluation of analytical methods used in sirolimus therapeutic drug monitoring

G. Horowitz, D. Holt, D. Mandelbrot, 2014, Clinical transplantation.

An immunoassay for the measurement of sirolimus.

D. Holt, T. Lee, A. Johnston, 2000, Clinical therapeutics.

Measurement of sirolimus in whole blood using high-performance liquid chromatography with ultraviolet detection.

D. Holt, T. Lee, A. Johnston, 2000, Clinical therapeutics.

Monitoring New Immunosuppressive Agents Are the Methods Adequate?

D. Holt, A. Johnston, 1997, Drug metabolism and drug interactions.

Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.

D. Holt, A. Johnston, T. Cairns, 1990, Transplantation proceedings.

Analytic Aspects of Cyclosporine Monitoring, on Behalf of the IFCC/IATDMCT Joint Working Group

L. Shaw, V. Armstrong, A. Griesmacher, 2004, Therapeutic drug monitoring.

Quality Assurance Programs for Immunosuppressive Drugs: Cyclosporine and Beyond

D. Holt, A. Johnston, K. Jones, 1993, Therapeutic drug monitoring.

Sandimmun neoral pharmacokinetics: impact of the new oral formulation.

J. Kovarik, D. Holt, E. Mueller, 1995, Transplantation proceedings.

Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum.

D. Holt, R. Flanagan, A. Johnston, 1981, Journal of chromatography.

Mitochondrial calcium deposition in association with cyclosporine therapy and myocardial magnesium depletion: a serial histologic study in heart transplant recipients.

A. Camm, D. Holt, T. Millane, 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The impact of cyclosporin formulation on clinical outcomes.

D. Holt, A. Johnston, 2000, Transplantation proceedings.

Measurement of reverse triiodothyronine as a guide to amiodarone therapy

W. Mckenna, D. Holt, E. Rowland, 1984 .

Effects of amiodarone on the kinetics of antipyrine.

W. Mckenna, D. Holt, A. Johnston, 1989, American Journal of Cardiology.

AMIODARONE DRUG-INTERACTIONS

W. Mckenna, D. Holt, A. Johnston, 1987 .

Amiodarone pharmacokinetics.

W. Mckenna, G. Tucker, D. Holt, 1986, British journal of clinical practice. Supplement.

High-performance liquid chromatographic method for the measurement of nicardipine in plasma or serum.

D. Holt, C. Galustian, R. Bhamra, 1990, Journal of chromatography.

Verapamil and breast-feeding

D. Holt, M. R. Miller, R. Bhamra, 2004, European Journal of Clinical Pharmacology.

High performance liquid chromatographic measurement of atenolol placental transfer and expression in breast milk

D. Holt, K. Thorley, G. Jackson, 1982 .

The first reported UK fatality related to gamma-butyrolactone (GBL) ingestion

J. Ramsey, P. Dargan, D. Holt, 2009, Journal of the Royal Society of Medicine.

Radioimmunoassays for Spirapril and Its Active Metabolite Spiraprilate: Performance and Application

D. Holt, A. Surve, Christophe Gerbeau, 1992, Therapeutic drug monitoring.

Electrophysiological properties of mexiletine assessed with respect to plasma concentrations.

D. Holt, S. Joseph, 1980, European journal of cardiology.

The United Kingdom Cyclosporin Quality Assessment Scheme.

D. Holt, A. Johnston, J. Marsden, 1986, Therapeutic drug monitoring.

External quality assessment scheme for cyclosporin in body fluids.

D. Holt, A. Johnston, 1993, Scandinavian journal of clinical and laboratory investigation. Supplementum.

CYCLOSPORIN RADIOIMMUNOASSAY AND CARDIAC TRANSPLANTATION

D. Holt, D. Bateman, J. Dark, 1988, The Lancet.

The influence of haematocrit on blood cyclosporin measurements in vivo.

D. Holt, A. Johnston, J. Marsden, 1988, British journal of clinical pharmacology.

Calibration of the CYCLO-Trac SP cyclosporine radioimmunoassay.

D. Holt, A. Johnston, 1993, Clinical chemistry.

Quality assurance for cyclosporin assays in body fluids.

D. Holt, A. Johnston, G. Cullen, 1991, Annals of the Academy of Medicine, Singapore.

Performance of the Sandoz radioimmunoassays for cyclosporine.

D. Holt, A. Johnston, J. Marsden, 1990, Transplantation proceedings.

Cyclosporine monitoring with polyclonal and specific monoclonal antibodies during episodes of renal allograft dysfunction.

D. Holt, A. Johnston, D. Taube, 1989, Transplantation proceedings.

Monoclonal antibodies for the radioimmunoassay of cyclosporine.

D. Holt, A. Johnston, J. Marsden, 1988, Transplantation proceedings.

Monoclonal antibodies for radioimmunoassay of cyclosporine: a multicenter comparison of their performance with the Sandoz polyclonal radioimmunoassay kit.

L. Shaw, D. Holt, P. Keown, 1988, Clinical chemistry.

HPLC and CYCLO-Trac SP radioimmunoassay compared for monitoring cyclosporine.

D. Holt, A. Johnson, 1992, Clinical Chemistry.

Cyclosporin monitoring: its role in autoimmune indications.

D. Holt, A. Johnston, 1992, Journal of autoimmunity.

Cyclosporine blood concentrations in the management of renal transplant recipients.

D. Holt, M. Bewick, K. E. Reid, 1986, Transplantation.

Sample pretreatment to minimize interference from whole blood in the radioimmunoassay for cyclosporine.

D. Holt, A. Johnston, J. Marsden, 1987, Transplantation.

Penetration ofdigoxin into cerebrospinal fluid

G. Schott, D. Holt, A. Hayler, 1976 .

TGF-beta quantitation can be tricky.

D. Holt, S. Fredericks, 1999, Transplantation.

Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage.

D. Holt, J. Murtagh, D. Nicholls, 1985, British heart journal.

Clinically significant interaction between digoxin and quinidine.

D. Holt, M. Edmonds, A. Hayler, 1979, British medical journal.

The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction

P. Emery, D. Holt, J. Upward, 2004, European Journal of Clinical Pharmacology.

Predicting patients' exposure to cyclosporin

J. Kovarik, D. Holt, E. Mueller, 1996, Transplant international : official journal of the European Society for Organ Transplantation.

Amiodarone disposition: Polyexponential, power and gamma functions

G. T. Tucker, G. Tucker, D. Holt, 2004, European Journal of Clinical Pharmacology.

Efficacy and Side Effects of Amiodarone for Resistant Arrhythmias in Childhood

G. Sutherland, D. Holt, P. Curry, 1986 .

Comparison of two strategies for myocardial management during coronary artery operations.

T. Treasure, D. Holt, J. Anderson, 1994, The Annals of thoracic surgery.

Comment on immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes.

J. Kaski, D. Holt, V. Bertomeu-González, 2006, Clinical chemistry.

Patient management by cyclosporine C2 monitoring.

D. Holt, A. Johnston, A. Jorga, 2004, Transplantation.

A survey to determine the blood concentration of cyclosporine 2 hours postdose in stable renal transplant patients.

M. Yaqoob, D. Holt, A. Johnston, 2004, Transplantation proceedings.

A New Pumpside Aid For Decision Making : The Pocket Programmable Calculator

D. Holt, J. Mandl, 1997 .

The Smell of Death: An Unusual Case of Poisoning With the Organophosphorus Pesticide Chlorfenvinphos.

L. Couchman, D. Holt, A. Johnston, 2018, Therapeutic drug monitoring.

Measurement of mycophenolate mofetil plasma levels after heart transplantation and a potential side effect of high levels.

N. Banner, D. Holt, S. Dubrey, 1999, Therapeutic drug monitoring.

Changing stable heart transplant recipients from Sandimmune to Neoral.

D. Holt, B. Madden, A. Murday, 1996, Transplantation proceedings.

Multi‐drug resistance gene‐1 (MDR‐1) haplotypes and the CYP3A5*1 genotype have no influence on ciclosporin dose requirements as assessed by C0 or C2 measurements

D. Holt, I. Macphee, M. Moreton, 2007, Clinical transplantation.

S-100 protein release in a range of cardiothoracic surgical procedures.

T. Treasure, D. Holt, K. Dhital, 1997, The Journal of thoracic and cardiovascular surgery.

Urinary proteins as a marker of drug-induced renal damage following treatment with cyclosporine or FK 506.

J. Tredger, J. Devlin, D. Holt, 1991, Transplantation proceedings.

S-100 Protein Release in a Range of Cardiothoracic Surgical Procedures

T. Treasure, D. Holt, Sahil Patel, 1997 .

Acute kidney injury reduces the hepatic metabolism of midazolam in critically ill patients

D. Holt, B. Philips, C. Kirwan, 2011, Intensive Care Medicine.

Evidence for T cell involvement in dilated cardiomyopathy: interleukin-2 receptor levels are high and related to endomyocardial biopsy markers of immune activation

W. Mckenna, D. Holt, J. Mann, 1993 .

The digoxin-amiodarone interaction

D. Holt, W. McKenna, A. Johnston, 1989, Cardiovascular Drugs and Therapy.

The role of cardiac troponin T to predict heart transplant rejection.

D. Holt, J. Anderson, 1999, The Annals of thoracic surgery.

Changes in salivary immunoglobulin A (IgA) following match-play and training among English premiership footballers.

D. Holt, G. Shaw, S. Fredericks, 2012, The Medical journal of Malaysia.

Therapeutic Drug Monitoring of Mycophenolate Mofetil in Transplantation

L. Shaw, B. Meiser, B. Toenshoff, 2006 .

Falsified Medicines in the European Union and North America: What are we doing to Protect Public Health?

D. Holt, Richard R Wilson, Julia Laín Abril, 2016 .

Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.

D. Holt, Y. Jamshidi, T. Nithiyananthan, 2010, The Journal of antimicrobial chemotherapy.

Editorial note Drug monitoring in children: for safety and efficacy

D. Holt, 1984 .

Use of recombinant factor VIIa (NovoSeven) in pediatric cardiac surgery.

D. Holt, H. Burkhart, S. Niles, 2008, The journal of extra-corporeal technology.

Effects of conventional ultrafiltration on renal performance during adult cardiopulmonary bypass procedures.

D. Holt, Bryan E. Thacker, Rick A. Kuntz, 2006, The journal of extra-corporeal technology.

Intraoperative assessment and quantification of coronary artery graft patency performed on or off cardiopulmonary bypass.

D. Holt, K. Strutz, C. Leach, 2007, The journal of extra-corporeal technology.

Evaluation offetal arrhythmias byechocardiography

Robert H. Anderson, D. Holt, M. Tynan, 1983 .

Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (pro-MBP) levels in patients with chronic stable angina pectoris.

J. Kaski, M. Christiansen, D. Holt, 2008, Clinica chimica acta; international journal of clinical chemistry.

Bioavailability of amiodarone

G. Tucker, D. Holt, G. Storey, 2004, European Journal of Clinical Pharmacology.

Biomarkers of Disease: Biomarkers in transplantation

J. Tredger, C. Price, D. Holt, 2002 .

Therapeutic Drug Monitoring of Everolimus: A Consensus Report

P. Marquet, C. Seger, K. Budde, 2016, Therapeutic drug monitoring.

Response to "Increased creatine kinase MB and cardiac troponin T with normal cardiac troponin I in metastatic alveolar rhabdomyosarcoma".

P. Collinson, D. Holt, S. Fredericks, 2000, Clinical chemistry.

Osteoarthritis-like changes in the heterozygous sedc mouse associated with the HtrA1-Ddr2-Mmp-13 degradative pathway: a new model of osteoarthritis.

L. Bridgewater, D. Holt, D. Kooyman, 2012, Osteoarthritis and cartilage.

Flow Awareness as a New Safety Device for Cardiopulmonary Bypass.

D. Holt, Jacki Brolhorst, Brittney Peterson, 2019, The journal of extra-corporeal technology.

Cardiac troponin-I content of skeletal muscle in patients with renal failure.

P. Collinson, D. Holt, D. Gaze, 2002, Clinical biochemistry.

Predicting patients’ exposure to cyclosporin

J. Kovarik, D. Holt, E. Mueller, 1996 .